Developing clinical trial protocols that include more diverse populations offers opportunity to product developers, marketers
In the past several years, the clinical research landscape has changed in many ways. The COVID-19 pandemic accelerated the uptake of decentralized or virtual trials; greater focus on gender issues, including health disparities, has increased awareness of a need for gender balance in studies. This, in turn, has expanded to encompass all aspects of diversity in clinical research.